Kayyali Chair for Pharmaceutical Industries, Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Department of Pharmaceutics, College of Pharmacy, Al-Azhar University, Assiut, Egypt.
Int J Nanomedicine. 2019 Jun 27;14:4625-4636. doi: 10.2147/IJN.S207301. eCollection 2019.
Rosuvastatin calcium (ROSCa) nanoparticles were fabricated by planetary ball mill to enhance ROSCa dissolution rate and bioavailability.
Milling time factors (milling cycle time and number as well as pause time) were explored. The effect of different milling ball size, speed, and solid-to-solvent ratio were also studied using Box-Behnken factorial design. The fabricated nanoparticles were evaluated in term of physicochemical properties and long-term stability.
The obtained data revealed that the integrated formulation and process factors should be monitored to obtain desirable nanoparticle attributes in terms of particle size, zeta potential, dissolution rate, and bioavailability. The optimized ROSCa nanoparticles prepared by milling technique showed a significant enhancement in the dissolution rate by 1.3-fold and the plasma concentration increased by 2-fold (<0.05). Moreover, stability study showed that the optimized formula of ROSCa nanoparticles exhibits higher stability in long-term stability conditions at 30°C with humidity of 60%.
Formulation of ROSCa as nanoparticles using milling technique showed a significant enhancement in both dissolution rate and plasma concentration as well as stability compared with untreated drug.
通过行星球磨法制备瑞舒伐他汀钙(ROSCa)纳米粒,以提高 ROSCa 的溶解速率和生物利用度。
考察了研磨时间因素(研磨循环时间、次数和暂停时间)。还使用 Box-Behnken 析因设计研究了不同研磨球大小、速度和固液比的影响。通过物理化学性质和长期稳定性评估了所制备的纳米粒。
获得的数据表明,应监测综合配方和工艺因素,以获得理想的纳米粒特性,包括粒径、Zeta 电位、溶解速率和生物利用度。通过研磨技术制备的优化的 ROSCa 纳米粒在溶解速率方面提高了 1.3 倍,血浆浓度提高了 2 倍(<0.05)。此外,稳定性研究表明,在 30°C、湿度为 60%的长期稳定性条件下,优化的 ROSCa 纳米粒配方表现出更高的稳定性。
与未处理的药物相比,使用研磨技术将 ROSCa 制成纳米粒在溶解速率、血浆浓度和稳定性方面均有显著提高。